Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 5:10 pm Purchase |
2025-04-07 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
MAVERICK CAPITAL LTD | 5,547,175 5.200% |
5,547,175 (New Position) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 8,261,242 5.400% |
-186,562 (-2.21%) |
Filing History |
| 2025-02-14 4:15 pm Sale |
2024-12-31 | 13G | Verona Pharma plc VRNA |
MAVERICK CAPITAL LTD | 25,028,128 3.800% |
-8,699,656 (-25.79%) |
Filing History |
| 2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Curis, Inc. CRIS |
MAVERICK CAPITAL LTD | 681,381 8.000% |
99,108 (+17.02%) |
Filing History |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
MAVERICK CAPITAL LTD | 33,727,784 5.200% |
33,727,784 (New Position) |
Filing History |
| 2024-11-14 4:30 pm Purchase |
2024-09-30 | 13G | Invivyd, Inc. IVVD |
MAVERICK CAPITAL LTD | 11,765,787 9.900% |
2,421,838 (+25.92%) |
Filing History |
| 2024-11-14 4:30 pm Purchase |
2024-09-30 | 13G | Fractyl Health, Inc. Common Stock GUTS |
MAVERICK CAPITAL LTD | 4,248,492 8.900% |
4,248,492 (New Position) |
Filing History |
| 2024-02-14 5:12 pm Purchase |
2023-12-31 | 13G | Invivyd, Inc. IVVD |
MAVERICK CAPITAL LTD | 9,343,949 8.500% |
9,343,949 (New Position) |
Filing History |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
MAVERICK CAPITAL LTD | 0 0.000% |
-251,641 (Position Closed) |
Filing History |
| 2024-02-14 5:02 pm Purchase |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 8,447,804 6.900% |
1,350,140 (+19.02%) |
Filing History |
| 2024-02-14 5:01 pm Unchanged |
2023-11-27 | 13D | Global Technology Acquisition Corp. I GTAC |
MAVERICK CAPITAL LTD | 1,200,000 35.400% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Curis, Inc. CRIS |
MAVERICK CAPITAL LTD | 582,273 9.900% |
582,273 (New Position) |
Filing History |
| 2023-05-23 5:23 pm Unchanged |
2023-04-20 | 13D | Global Technology Acquisition Corp. I GTAC |
MAVERICK CAPITAL LTD | 1,200,000 57.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 11:57 am Sale |
2022-12-31 | 13G | Population Health Investment Co., Inc. PHIC |
MAVERICK CAPITAL LTD | 0 0.000% |
-1,185,260 (Position Closed) |
Filing History |
| 2023-02-14 11:53 am Purchase |
2022-12-31 | 13G | Wave Life Sciences Ltd. WVE |
MAVERICK CAPITAL LTD | 7,097,664 8.200% |
1,504,275 (+26.89%) |
Filing History |
| 2023-02-14 07:38 am Unchanged |
2022-12-31 | 13G | Dragoneer Growth Opportunities Corp. III DGNU |
MAVERICK CAPITAL LTD | 3,000,000 7.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 07:36 am Purchase |
2022-12-31 | 13G | Global Technology Acquisition Corp. I GTAC |
MAVERICK CAPITAL LTD | 1,200,000 6.000% |
1,200,000 (New Position) |
Filing History |
| 2023-02-14 07:34 am Unchanged |
2022-12-31 | 13G | Panacea Acquisition Corp. II PANA |
MAVERICK CAPITAL LTD | 1,385,250 7.800% |
0 (Unchanged) |
Filing History |
| 2023-02-14 07:34 am Sale |
2022-12-31 | 13G | Coupang, Inc. CPNG |
MAVERICK CAPITAL LTD | 76,202,904 4.800% |
-18,591,081 (-19.61%) |
Filing History |
| 2023-02-14 07:32 am Sale |
2022-12-31 | 13G | Orion Acquisition Corp. OHPAU |
MAVERICK CAPITAL LTD | 0 0.000% |
-2,672,349 (Position Closed) |
Filing History |